Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 276INDUSTRY 119NIH 33NETWORK 6OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Gemcitabine 15Cisplatin 12Radiotherapy 11Metformin 8Fluorouracil 8Capecitabine 8Paclitaxel 7Oxaliplatin 7Exercise 7Indocyanine Green 6Docetaxel 6Cyclophosphamide 6Control Groups 6Surveys and Questionnaires 5Standard of Care 5Nivolumab 5Letrozole 5Irinotecan 5pembrolizumab 4durvalumab 4Zoledronic Acid 4Vinorelbine 4Saline Solution 4Preoperative Exercise 4Magnetic Resonance Spectroscopy 4Leucovorin 4Ifosfamide 4Gefitinib 4Drug Therapy 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × Lenalidomide × Clear all
NCT04214626 2025-11-19

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Completed
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04065789 2022-01-27

KyDaR

Tel-Aviv Sourasky Medical Center

Phase 2 Completed
41 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡